The FDA has approved Quillivant XR (methylphenidate hydrochloride) from Next Wave Pharma for extended-release oral suspension for treatment of Attention...
The Federal Patent Court in Germany has found the formulation patent protecting Seroquel XR (quetiapine fumarate) prolonged-release tablets � marketed...
Pfizer has announced that the FDA has approved Xeljanz XR (tofacitinib citrate) extended-release 11 mg tablets for the once-daily treatment...
The FDA has informed Veloxis of the tentative approval of Envarsus XR (tacrolimus extended relief) for Transplant Rejection. The FDA...
Veloxis Pharmaceuticals A/S announced that Envarsus XR (extended release tacrolimus) was granted Orphan Drug status by the U.S. Food and...
On 5th November 2010 the FDA approved Kombiglyze XR from BMS/AstraZeneca, for the treatment of type 2 diabetes in adults....
AstraZeneca have announced that the FDA has approved once-daily Xigduo XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of...
Veloxis Pharmaceuticals has submitted a supplemental New Drug Application (sNDA) to the FDA seeking a new indication for Envarsus XR...
Mallinckrodt plc announced that the FDA has on 11 March 2014 approved Xartemis XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets...
The FDA has approved the New Drug Application (NDA) for Tuzistra XR (codeine polistirex and chlorpheniramine polistirex) extended-release oral suspension,...